Nothing Special   »   [go: up one dir, main page]

FR2684877B1 - Procede pour la preparation d'une composition pharmaceutique abaissant selectivement les taux de lipides dans le sang et composition ainsi obtenue. - Google Patents

Procede pour la preparation d'une composition pharmaceutique abaissant selectivement les taux de lipides dans le sang et composition ainsi obtenue.

Info

Publication number
FR2684877B1
FR2684877B1 FR9214822A FR9214822A FR2684877B1 FR 2684877 B1 FR2684877 B1 FR 2684877B1 FR 9214822 A FR9214822 A FR 9214822A FR 9214822 A FR9214822 A FR 9214822A FR 2684877 B1 FR2684877 B1 FR 2684877B1
Authority
FR
France
Prior art keywords
composition
lipids
blood
preparation
rate
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR9214822A
Other languages
English (en)
Other versions
FR2684877A1 (fr
Inventor
Hidvegi Mate Dr
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of FR2684877A1 publication Critical patent/FR2684877A1/fr
Application granted granted Critical
Publication of FR2684877B1 publication Critical patent/FR2684877B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/12—Drugs for disorders of the metabolism for electrolyte homeostasis
    • A61P3/14—Drugs for disorders of the metabolism for electrolyte homeostasis for calcium homeostasis

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Medical Informatics (AREA)
  • Mycology (AREA)
  • Biotechnology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Rheumatology (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
FR9214822A 1991-12-12 1992-12-09 Procede pour la preparation d'une composition pharmaceutique abaissant selectivement les taux de lipides dans le sang et composition ainsi obtenue. Expired - Fee Related FR2684877B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU913928A HU208256B (en) 1991-12-12 1991-12-12 Process for producing pharmaceutical compositions suitable for the selective reduction of lipoid level of blood

Publications (2)

Publication Number Publication Date
FR2684877A1 FR2684877A1 (fr) 1993-06-18
FR2684877B1 true FR2684877B1 (fr) 1994-12-30

Family

ID=10966105

Family Applications (1)

Application Number Title Priority Date Filing Date
FR9214822A Expired - Fee Related FR2684877B1 (fr) 1991-12-12 1992-12-09 Procede pour la preparation d'une composition pharmaceutique abaissant selectivement les taux de lipides dans le sang et composition ainsi obtenue.

Country Status (25)

Country Link
US (1) US5277910A (fr)
JP (1) JPH05286865A (fr)
KR (1) KR930012033A (fr)
CN (1) CN1074123A (fr)
AT (1) ATA243992A (fr)
AU (1) AU657822B2 (fr)
BE (1) BE1006341A3 (fr)
CA (1) CA2085215A1 (fr)
CZ (1) CZ363492A3 (fr)
DE (1) DE4242149A1 (fr)
DK (1) DK148092A (fr)
ES (1) ES2055659B1 (fr)
FI (1) FI925633A (fr)
FR (1) FR2684877B1 (fr)
GB (1) GB2262230B (fr)
GR (1) GR920100548A (fr)
HU (1) HU208256B (fr)
IL (1) IL104067A0 (fr)
IT (1) IT1256652B (fr)
LU (1) LU88200A1 (fr)
MX (1) MX9207222A (fr)
NL (1) NL9202144A (fr)
PL (1) PL296972A1 (fr)
SE (1) SE9203744L (fr)
ZA (1) ZA929622B (fr)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU208256B (en) * 1991-12-12 1993-09-28 Mate Hidvegi Process for producing pharmaceutical compositions suitable for the selective reduction of lipoid level of blood
AU7250694A (en) * 1993-06-25 1995-01-17 Biosphere Technologies Inc. Dietary supplement incorporating beta-sitosterol and pectin
US5674496A (en) * 1993-10-20 1997-10-07 New Mexico Tech Research Foundation Animal repellent
US6814962B1 (en) * 1994-06-02 2004-11-09 Aventis Pharma S.A. Recombinant viruses and their use for treatment of atherosclerosis and other forms of coronary artery disease and method, reagent, and kit for evaluating susceptibility to same
US5516528A (en) * 1995-01-13 1996-05-14 Wake Forest University Dietary phytoestrogen in estrogen replacement therapy
US6193766B1 (en) * 1996-06-27 2001-02-27 Barto/Jordan Company, Inc. Alfalfa extract fuel additive for reducing pollutant emissions
US6086882A (en) 1997-08-06 2000-07-11 National Institute For Pharmaceutical Research Phytodrug for management of peptic ulcer and methods of preparing and using same
US5786343A (en) * 1997-03-05 1998-07-28 Immudyne, Inc. Phagocytosis activator compositions and their use
GB2327607B8 (en) * 1997-07-31 2005-03-30 Litton Internat Company Ltd A process for producing a herbal extract composition
DE19750453A1 (de) * 1997-11-14 1999-05-27 Henkel Kgaa Verwendung von Wirkstoffmischungen zur Herstellung von hypocholesterinämischen Mitteln
US6232351B1 (en) 1998-05-22 2001-05-15 Amway Corporation Co-processed botanical plant composition
US6150399A (en) * 1998-06-30 2000-11-21 Abbott Laboratories Soy-based nutritional products
DE19857816C2 (de) * 1998-12-15 2001-02-01 Bionorica Arzneimittel Gmbh Fließfähige, pressfertige Arzneimittelvorprodukte für Tabletten, Pellets und Dragees, sowie Verfahren zu deren Herstellung
FR2794616B1 (fr) * 1999-06-11 2001-09-07 Tekory S A R L Supplement alimentaire naturel destine a diminuer le taux de cholesterol plasmatique et procede pour le preparer
US6866874B2 (en) 2000-05-26 2005-03-15 Susan P. Hudson Tryptophan source from plants and uses therefor
US6503543B1 (en) * 2000-05-26 2003-01-07 Craig J. Hudson Tryptophan source from plants and uses therefor
US20020119928A1 (en) * 2000-10-27 2002-08-29 Mcanalley Bill H. Dietary supplement compositions
US7815946B1 (en) * 2001-04-05 2010-10-19 Diakron Pharmaceuticals, Inc. Anti-diabetic and cholesterol lowering preparation from fenugreek seeds
JP5110673B2 (ja) * 2001-07-10 2012-12-26 丸善製薬株式会社 リパーゼ阻害剤
FR2854769B1 (fr) * 2003-05-16 2009-07-17 Alfalis Utilisation d'un extrait soluble de luzerne pour freiner la prise de poids chez les mammiferes
US20090318377A1 (en) * 2006-07-13 2009-12-24 Medicago Inc. Medicagenic acid saponin and uses thereof
US20090226549A1 (en) * 2008-03-06 2009-09-10 Kenneth John Hughes Herbal extracts and flavor systems for oral products and methods of making the same
EP2590623A1 (fr) * 2010-07-06 2013-05-15 Unilever PLC Malvidine pour favoriser la pousse de cheveux
KR20200040583A (ko) 2018-10-10 2020-04-20 (주)아모레퍼시픽 코티존 환원효소 저해용 조성물
CN114853918B (zh) * 2022-04-26 2023-03-31 沈阳化工大学 一种具有抗氧化降脂活性的紫花苜蓿根部多糖制备方法
CN115490584B (zh) * 2022-09-28 2023-07-14 厦门中药厂有限公司 Megastigmane类化合物及其制备方法和应用

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1136626A (en) * 1965-10-22 1968-12-11 Nat Res Dev Improvements relating to the extraction of saponins and sapogenins from vegetable materials
US3780183A (en) * 1971-01-25 1973-12-18 Edwards G Wheeler Plant protein product and process
US3901875A (en) * 1972-03-31 1975-08-26 Pacific Chem Ind Co Extraction of ginseng saponin
GB1378278A (en) * 1972-03-31 1974-12-27 Pacific Chem Ind Co Total saponin extracts from panax ginseng c a meyer and process for the production thereof
FR2187328A1 (en) * 1972-06-13 1974-01-18 Froment Pier E De Non-saponified lucerne extract - useful in dermatology cosmetology and as aid to cicatrisation
SU624634A1 (ru) * 1975-09-25 1978-09-25 Харьковский Научно-Исследовательский Химико-Фармацевтический Институт Способ получени ингибитора,обладающего антифибринолитическим и противовоспалительным действием
JPS59166055A (ja) * 1983-03-11 1984-09-19 Osaka Chem Lab 牧草を原料とする食品
JPS59175496A (ja) * 1983-03-23 1984-10-04 Osaka Chem Lab ソ−ヤサポニンの単離法
JPS646987A (en) * 1987-06-30 1989-01-11 Ricoh Kk Controlling method for toner concentration of developer for electrophotographic device
FR2669225B1 (fr) * 1990-11-21 1993-11-12 Lvmh Recherche Gie Utilisation de saponines de medicago pour la preparation de compositions cosmetiques ou pharmaceutiques, notamment dermatologiques.
HU208256B (en) * 1991-12-12 1993-09-28 Mate Hidvegi Process for producing pharmaceutical compositions suitable for the selective reduction of lipoid level of blood

Also Published As

Publication number Publication date
DK148092D0 (da) 1992-12-09
CN1074123A (zh) 1993-07-14
NL9202144A (nl) 1993-07-01
SE9203744L (sv) 1993-06-13
GR920100548A (el) 1993-08-31
GB9225866D0 (en) 1993-02-03
DK148092A (da) 1993-06-13
FI925633A0 (fi) 1992-12-11
IT1256652B (it) 1995-12-12
LU88200A1 (fr) 1993-04-15
ITMI922842A1 (it) 1994-06-11
AU657822B2 (en) 1995-03-23
FR2684877A1 (fr) 1993-06-18
DE4242149A1 (fr) 1993-06-17
GB2262230B (en) 1995-10-11
FI925633A (fi) 1993-06-13
ZA929622B (en) 1995-09-26
CZ363492A3 (en) 1993-09-15
US5277910A (en) 1994-01-11
HU208256B (en) 1993-09-28
ATA243992A (de) 2000-02-15
IL104067A0 (en) 1993-05-13
HU913928D0 (en) 1992-02-28
BE1006341A3 (fr) 1994-07-26
ES2055659B1 (es) 1995-03-01
AU3005492A (en) 1993-06-17
MX9207222A (es) 1993-06-01
KR930012033A (ko) 1993-07-20
CA2085215A1 (fr) 1993-06-13
JPH05286865A (ja) 1993-11-02
PL296972A1 (en) 1993-08-23
SE9203744D0 (sv) 1992-12-11
GB2262230A (en) 1993-06-16
ES2055659A1 (es) 1994-08-16
ITMI922842A0 (it) 1992-12-11

Similar Documents

Publication Publication Date Title
FR2684877B1 (fr) Procede pour la preparation d'une composition pharmaceutique abaissant selectivement les taux de lipides dans le sang et composition ainsi obtenue.
FR2665898B1 (fr) Derives d'amido-3 pyrazole, procede pour leur preparation et compositions pharmaceutiques les contenant.
MA26471A1 (fr) Derives d'acide arylsulfonylaminohydroxamique, procede pour leur preparation et compositions pharmaceutiques les contenant.
FR2650182B1 (fr) Procede de preparation d'une composition pharmaceutique sous forme de microparticules
FR2680109B1 (fr) Composition pour la liberation prolongee et controlee et controlee d'une substance medicamenteuse peptidique et procede pour sa preparation.
FR2620352B1 (fr) Procede et produit pour la preparation d'emulsions d'hydrocarbures visqueux dans l'eau et emulsions ainsi preparees
BE893394A (fr) Bandage pour l'administration d'une substance pharmaceutique
MA21645A1 (fr) Procede pour la preparation de nouveaux derives d'rtemisinine.
FR2684554B1 (fr) Medicaments pour le traitement d'etats inflammatoires ou pour l'analgesie.
FR2501204B1 (fr) Derives d'un acide quinoleine-carboxylique, procede pour les preparer et medicament en contenant
MA22443A1 (fr) Procede de preparation d'une composition pharmaceutique .
FR2499408B1 (fr) Composition pharmaceutique pour le traitement de l'osteopathie, a base d'acide 6-amino-1-hydroxyhexane-1,1-diphosphonique
FR2628973B1 (fr) Composition cosmetique ou pharmaceutique a usage cutane, et procede pour la preparation d'une telle composition
PT78275B (fr) Procede de preparation de nouveaux acides flavone-carboxyliques-4' et de compositions pharmaceutiques les contenant
FR2663338B1 (fr) Polyether-esters, procede pour leur preparation, compositions les contenant et leur utilisation dans l'appretage de materiaux fibreux.
PT87651A (pt) Procede de preparation d'une composition pour adhesive thermofusible reticulable d'adhesifs la contenant et procede de collage
FR2635115B1 (fr) Procede de preparation de la serum albumine humaine a partir d'une levure
FR2666334B1 (fr) Procede continu de preparation d'acrylamides et de methacrylamides n-substitues.
FR2548538B1 (fr) Production d'interferon humain et procede pour le dosage de l'aptitude du sang a produire de l'interferon
FR2558372B1 (fr) Composition medicamenteuse pour le traitement de l'acne
FR2736914B1 (fr) Nouveaux derives d'acide aminophenylphosphonique, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
MC2072A1 (fr) Procede pour la preparation d'une proteine hybride
FR2563519B1 (fr) Derives d'iminothiazolidine, procede pour leur preparation et compositions pharmaceutiques les contenant
FR2718024B1 (fr) Médicament et composition pharmaceutique pour le traitement de l'inflammation.
FR2720944B1 (fr) Composition thérapeutique ou diététique sous forme de gel médicamenteux pour l'administration à des animaux de compagnie.

Legal Events

Date Code Title Description
ST Notification of lapse